STEPHANIE BURNETT: Open Payments
NPI 1477135200 · THOMSON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,923 in 148 payments from 18 companies in 2025. Trend: 2023 $1,161 · 2024 $1,615 · 2025 $2,923
Food & beverage: $2,923
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $612 |
| Janssen Biotech, Inc. | 21 | $550 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 35 | $550 |
| Madrigal Pharmaceuticals | 8 | $312 |
| Intercept Pharmaceuticals, Inc. | 4 | $141 |
| QOL Medical, LLC | 6 | $139 |
| Aimmune Therapeutics, Inc. | 7 | $106 |
| Biocon Biologics Inc | 4 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $72 |
| Regeneron Healthcare Solutions, Inc. | 3 | $72 |
Products named: TREMFYA, XIFAXAN, RINVOQ, REZDIFFRA, OCALIVA, Sucraid, DUPIXENT, ZENPEP.
Industry payments across GA — which companies pay providers there.
